Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia

Cellular Signalling

Volumn 27, Issue 3, 2015, Pages 443-452

  Wang, Xi ^a   Li, Jinge ^a   Dong, Ke ^a   Lin, Fang ^a   Long, Min ^a   Ouyang, Yongri ^a   Wei, Junxia ^a   Chen, Xi ^a   Weng, Yuanyuan ^a   He, Ting ^a   Zhang, Huizhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AML immunoresistance; PD L1 miR 34a

Indexed keywords

MICRORNA 34A; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN KINASE B; AKT1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ARSENIC TRIOXIDE; CD274 PROTEIN, HUMAN; GAMMA INTERFERON; MICRORNA; MIRN34 MICRORNA, HUMAN; ORGANOARSENIC DERIVATIVE; OXIDE; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; MUTAGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; T LYMPHOCYTE; TRANSCRIPTION REGULATION; ACUTE MYELOBLASTIC LEUKEMIA; AGED; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HL 60 CELL LINE; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE; UPREGULATION;

AGED; ANTIGENS, CD274; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; BASE SEQUENCE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; INTERFERON-GAMMA; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDES, ANTISENSE; OXIDES; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; UP-REGULATION;

EID: 84921028577     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.12.003     Document Type: Article

References (38)

1. Cresswell P., Ackerman A.L., Giodini A., Peaper D.R., Wearsch P.A. Immunol. Rev. 2005, 207:145-157.
2. Raghavan M., Del C.N., Rizvi S.M., Peters L.R. Trends Immunol. 2008, 29:436-443.
3. Kalergis A.M., Boucheron N., Doucey M.A., Palmieri E., Goyarts E.C., Vegh Z., Luescher I.F., Nathenson S.G. Nat. Immunol. 2001, 2:229-234.
4. Saito T., Yamasaki S. Immunol. Rev. 2003, 192:143-160.
5. Z.G., Dong H., Tamada K., C.L. Nature Medicine 1999, 1365-1369.
6. Cunha L.L., Marcello M.A., Morari E.C., Nonogaki S., Conte F.F., Gerhard R., Soares F.A., Vassallo J., Ward L.S. Endocr. Relat. Cancer 2013, 20:103-110.
7. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., Sharpe A.H. J. Exp. Med. 2009, 206:3015-3029.
8. Yang W., Song Y., Lu Y.L., Sun J.Z., Wang H.W. Immunology 2013, 139:513-522.
9. Liu S.M., Meng Q., Zhang Q.X., Wang S.D., Liu Z.J., Zhang X.F. Zhonghua Zhong Liu Za Zhi 2008, 30:192-195.
10. Nomi T., Sho M., Akahori T., Hamada K., Kubo A., Kanehiro H., Nakamura S., Enomoto K., Yagita H., Azuma M., Nakajima Y. Clin. Cancer Res. 2007, 13:2151-2157.
11. Hino R., Kabashima K., Kato Y., Yagi H., Nakamura M., Honjo T., Okazaki T., Tokura Y. Cancer 2010, 116:1757-1766.
12. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., Lennon V.A., Celis E., Chen L. Nat. Med. 2002, 8:793-800.
13. Zhang P., Su D.M., Liang M., Fu J. Mol. Immunol. 2008, 45:1470-1476.
14. Bartel D.P. Cell 2004, 116:281-297.
15. Fabian M.R., Sonenberg N., Filipowicz W. Annu. Rev. Biochem. 2010, 79:351-379.
16. Chen K., Rajewsky N. Nat. Rev. Genet. 2007, 8:93-103.
17. Lee D.Y., Shatseva T., Jeyapalan Z., Du WW Z.Deng, Yang B.B. PLoS One 2009, 4:e4527.
18. Chen C.Z. N. Engl. J. Med. 2005, 353:1768-1771.
19. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. Nature 2005, 435:839-843.
20. Li X., Zhang Y., Shi Y., Dong G., Liang J., Han Y., Wang X., Zhao Q., Ding J., Wu K., Fan D. J. Cell. Mol. Med. 2011, 15:1887-1895.
21. Ha T.Y. Immune Netw. 2011, 11:11-41.
22. Wendlandt E.B., Graff J.W., Gioannini T.L., McCaffrey A.P., Wilson M.E. Innate Immun. 2012, 18:846-855.
23. Lai L., Song Y., Liu Y., Chen Q., Han Q., Chen W., Pan T., Zhang Y., Cao X., Wang Q. J. Biol. Chem. 2013, 288:7956-7967.
24. Xu H., Cheung I.Y., Guo H.F., Cheung N.K. Cancer Res. 2009, 69:6275-6281.
25. Parsa A.T., Waldron J.S., Panner A., Crane C.A., Parney I.F., Barry J.J., Cachola K.E., Murray J.C., Tihan T., Jensen M.C., Mischel P.S., Stokoe D., Pieper R.O. Nat. Med. 2007, 13:84-88.
26. Zhang Y., Zhang J., Xu K., Xiao Z., Sun J., Xu J., Wang J., Tang Q. Hepatogastroenterology 2013, 60:1766-1772.
27. Gong A.Y., Zhou R., Hu G., Li X., Splinter P.L., O'Hara S.P., LaRusso N.F., Soukup G.A., Dong H., Chen X.M. J. Immunol. 2009, 182:1325-1333.
28. Wang W., Li F., Mao Y., Zhou H., Sun J., Li R., Liu C., Chen W., Hua D., Zhang X. Hum. Genet. 2013, 132:641-648.
29. Mraz M., Malinova K., Kotaskova J., Pavlova S., Tichy B., Malcikova J., Stano K.K., Smardova J., Brychtova Y., Doubek M., Trbusek M., Mayer J., Pospisilova S. Leukemia 2009, 23:1159-1163.
30. Zhang D., Zhou J., Dong M. Dig. Dis. Sci. 2014, 59:958-967.
31. Shi Y., Liu C., Liu X., Tang D.G., Wang J. PLoS One 2014, 9:e90022.
32. Guessous F., Zhang Y., Kofman A., Catania A., Li Y., Schiff D., Purow B., Abounader R. Cell Cycle 2010, 9:1031-1036.
33. Yamamura S., Saini S., Majid S., Hirata H., Ueno K., Deng G., Dahiya R. PLoS One 2012, 7:e29722.
34. Hobo W., Maas F., Adisty N., de Witte T., Schaap N., van der Voort R., Dolstra H. Blood 2010, 116:4501-4511.
35. Zhang P., Sun D., Ke Y., Kaplan H.J., Shao H. J. Immunol. 2007, 178:474-479.
36. Lewis B.P., Shih M.W.J.I.H., Bartel a.C.B.B.D.P. Cell 2003, 787-798.
37. Wiggins J.F., Ruffino L., Kelnar K., Omotola M., Patrawala L., Brown D., Bader A.G. Cancer Res. 2010, 70:5923-5930.
38. Bader A.G. Front. Genet. 2012, 3:120.